D

DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620

Watchlist Manager
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
Watchlist
Price: 5 210 KRW 0.19% Market Closed
Market Cap: 148.3B KRW

Net Margin
DongKoo Bio & Pharma Co Ltd

0.3%
Current
3%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.3%
=
Net Income
770.3m
/
Revenue
238.4B

Net Margin Across Competitors

No Stocks Found

DongKoo Bio & Pharma Co Ltd
Glance View

Market Cap
140.9B KRW
Industry
Pharmaceuticals

DongKoo Bio & Pharm Co. Ltd. operates as a holding company engaged in the manufacture and sale of pharmaceutical products and health supplements. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-02-13. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The firm is involved in contract manufacturing organization business. The company manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The firm distributes its products within the domestic market and to overseas markets, including America and Europe.

DongKoo Bio & Pharma Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.3%
=
Net Income
770.3m
/
Revenue
238.4B
What is the Net Margin of DongKoo Bio & Pharma Co Ltd?

Based on DongKoo Bio & Pharma Co Ltd's most recent financial statements, the company has Net Margin of 0.3%.

Back to Top